Swissmedic Annual Report 2018

88 Corporate Governance
Revenues
Swissmedic is financed through fees and levies, payments
from the federal government for public services provided
and through payments received for services rendered to
third parties. To ensure that its control activities are efficient,
the Agency is managed according to the principles of
good business practice.
Revenues in 2018
As a percentage of total revenues
Fees 33,183 35.93 %
Levies 44,662 48.36 %
Payments from the federal government 14,056 15.22 %
Payments received for services rendered to third parties 150 0.16 %
Agency Council
The Agency Council is Swissmedic’s supervisory body. It
comprises a maximum of seven members and is appointed
by the Federal Council, which also designates the chair.
Three members may be proposed by the Cantons. The term
of office is four years. The duties of the Agency Council are
similar to those of the board of directors of a public limited
company.
In its capacity as a strategic body, the Agency Council represents
Swissmedic’s interests vis-a-vis the Federal Office
and the Federal Council. It also tasked with approving the
Swissmedic budget, annual accounts and Annual Report.
The Agency Council’s responsibilities are set out in Art. 72
of the Therapeutic Products Act (TPA; the applicable version
in the reporting year).
Member
In office since
Dr. Stéphane Rossini (C) 2018
Ms. Vincenza Trivigno (VC) 2016
Dr. iur. Lukas Engelberger 2017
Prof. Olivier Guillod 2014
Prof. Reto Obrist 2010
Prof. Marie-Denise Schaller, MD 2018
Mr. Giovan Maria Zanini 2014
C = Chair; VC = Vice-Chair
The Agency Council comprises the following members (as
at 31 December 2018):